✦ LIBER ✦

Mapping of an HLA-DRw52-associated determinant on DRβ1 molecules

✍ Scribed by M. Ballas; T. H. Elermann; A. Wölpl; S. F. Goldmann

Book ID: 115094172
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 616 KB
Volume: 36
Category: Article
ISSN: 0001-2815
DOI: 10.1111/j.1399-0039.1990.tb01828.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of the HLA-DRB, HLA-DQB an

The influence of the HLA-DRB, HLA-DQB and polymorphic positions of the HLA-DRβ1 and HLA-DQβ1 molecules on risk of Iranian type 1 diabetes mellitus patients

✍ A. Sayad; M. T. Akbari; M. Pajouhi; F. Mostafavi; M. Zamani 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Amino acid position 11 of HLA-DRβ1 is a

Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis

✍ Achkar, J-P; Klei, L; Bakker, P I W de; Bellone, G; Rebert, N; Scott, R; Lu, Y; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 367 KB

An update on HLA association of Mi-2 aut

An update on HLA association of Mi-2 autoantibodies: The association with a tryptophan at position 9 of the HLA–DRβ chain is strong but not absolute

✍ Rudolf Mierau; Thomas Dick; Peter Bartz-Bazzanella; Elisabeth Keller; Ekkehard D 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

Cross-linking HLA-DR molecules on Th1 ce

Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27Kip1

✍ Hironori Kudo; Takako Matsuoka; Hiroaki Mitsuya; Yasuharu Nishimura; Sho Matsush 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Aspartic acid at position 57 of the HLA-

Aspartic acid at position 57 of the HLA-DQβ chain in insulin-dependent diabetes mellitus: An association with one DRw9–DQw9 subtype in the Chinese population

✍ L. Y. Ju; Y. P. Sun; G. Semana; X. F. Gu; R. Krishnamoorty; R. Fauchet; D. Charr 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Beneficial effect of interferon-β 1b tre

Beneficial effect of interferon-β 1b treatment in patients with relapsing–remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy

✍ Enrico Fainardi; Roberta Rizzo; Loredana Melchiorri; Massimiliano Castellazzi; V 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB